Excessive Matrix Metalloproteinase Activity in Diabetes: Inhibition by Tetracycline Analogues with Zinc Reactivity

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|8|3|305-316

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.8, Iss.3, 2001-02, pp. : 305-316

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic developments in matrix metalloproteinase inhibition

By Shah Prediman K   Wilkin Douglas J   Doherty Terence M   Uzui Hiroyasu   Rajavashisth Tripathi B   Asotra Kamlesh   Pei Duanqing  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 5, 2002-05 ,pp. : 665-707

Informa Healthcare

Access to resources Recommend Favorite

A Bioinorganic Perspective on Matrix Metalloproteinase Inhibition

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 15, 2004-11 ,pp. : 1551-1573

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphonate Emerging Zinc Binding Group in Matrix Metalloproteinase Inhibitors

By  

Current Drug Targets, Vol. 16, Iss. 14, 2015-12 ,pp. : 1634-11

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of gelatinase B (matrix metalloproteinase-9) by dihydrolipoic acid

By Cantin André M   Martel Marc   Drouin Geneviève   Paquette Benoit  

Canadian Journal of Physiology and Pharmacology, Vol. 83, Iss. 3, 2005-03 ,pp. : 301-308

NRC Research Press

Access to resources Recommend Favorite

Influence of Aldose Reductase Inhibition on the Microvascular Reactivity in Experimental Diabetes

By Fortes Z.B.   Becker C.   Oliveira M.A.   Scivoletto R.  

General Pharmacology, Vol. 27, Iss. 5, 1996-07 ,pp. : 917-921

Elsevier

Access to resources Recommend Favorite